WBR1502: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |Approved=No }}")
 
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=William J Gibson
|ExamType=USMLE Step 2 CK
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|MainCategory=Internal medicine
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|SubCategory=Neurology
|MainCategory=Internal medicine
|MainCategory=Internal medicine
|SubCategory=Neurology
|Prompt=A 43 year old man presents with three weeks of severe dysphagia to solids resulting in a 25 pound weight loss. He has oral candidiasis and is admitted for inpatient workup. EGD reveals esophageal stricture. The patient reports that since the onset of his dysphagia, he has stopped taking his anti-retroviral regimen due to difficulty swallowing. On day 4 of his admission, he reports headaches and his mental status begins deteriorating. An MRI with contrast is performed (shown below).
<br>
[[File:WBR1502]]
<br>
What is the most appropriate therapy to address the cause of this patient's neurological symptoms?
|AnswerA=Methotrexate
|AnswerAExp=Methotrexate is the preferred first line therapy for primary CNS lymphoma. The presence of multiple  enhancing lesions in this patient's MRI make the diagnosis of primary CNS lymphoma less likely than Toxoplasmosis.
|AnswerB=Dexamethasone
|AnswerBExp=[[Dexamethasone]] is a corticosteroid used to decrease inflammation that may be associated with increased inctracranial pressure. While this patient may have some increased intracranial pressure from his toxoplasma infection, dexamethasone would not be the definitive therapy.
|AnswerC=Trimethoprim-Sulfamethoxazole
|AnswerCExp=Trimethoprim-Sulfamethoxazole (TMP-SMX) is often used as a second agent in regimens against Toxoplasmosis. TMP-SMX is synergistic in combination with Pyrimethamine. However, TMP-SMX is not recommended as a monotherapy against Toxoplasmosis.
|AnswerD=Pyrimethamine
|AnswerDExp=Pyrimethamine is the drug of choice in treating Toxoplasmosis.
|AnswerE=Azithromycin
|AnswerEExp=The efficacy of azithromycin in treating Toxoplasmosis is unclear.
|EducationalObjectives=Multiple ring enhancing lesions in the brain of an HIV infected patient is highly concerning for cerebral Toxoplasmosis. Pyrimethamine is the preferred therapy.
|RightAnswer=D
|Approved=No
|Approved=No
}}
}}

Revision as of 23:14, 10 February 2016

 
Author PageAuthor::William J Gibson
Exam Type ExamType::USMLE Step 2 CK
Main Category MainCategory::Internal medicine
Sub Category SubCategory::Neurology
Prompt [[Prompt::A 43 year old man presents with three weeks of severe dysphagia to solids resulting in a 25 pound weight loss. He has oral candidiasis and is admitted for inpatient workup. EGD reveals esophageal stricture. The patient reports that since the onset of his dysphagia, he has stopped taking his anti-retroviral regimen due to difficulty swallowing. On day 4 of his admission, he reports headaches and his mental status begins deteriorating. An MRI with contrast is performed (shown below).


File:WBR1502
What is the most appropriate therapy to address the cause of this patient's neurological symptoms?]]

Answer A AnswerA::Methotrexate
Answer A Explanation AnswerAExp::Methotrexate is the preferred first line therapy for primary CNS lymphoma. The presence of multiple enhancing lesions in this patient's MRI make the diagnosis of primary CNS lymphoma less likely than Toxoplasmosis.
Answer B AnswerB::Dexamethasone
Answer B Explanation [[AnswerBExp::Dexamethasone is a corticosteroid used to decrease inflammation that may be associated with increased inctracranial pressure. While this patient may have some increased intracranial pressure from his toxoplasma infection, dexamethasone would not be the definitive therapy.]]
Answer C AnswerC::Trimethoprim-Sulfamethoxazole
Answer C Explanation AnswerCExp::Trimethoprim-Sulfamethoxazole (TMP-SMX) is often used as a second agent in regimens against Toxoplasmosis. TMP-SMX is synergistic in combination with Pyrimethamine. However, TMP-SMX is not recommended as a monotherapy against Toxoplasmosis.
Answer D AnswerD::Pyrimethamine
Answer D Explanation AnswerDExp::Pyrimethamine is the drug of choice in treating Toxoplasmosis.
Answer E AnswerE::Azithromycin
Answer E Explanation AnswerEExp::The efficacy of azithromycin in treating Toxoplasmosis is unclear.
Right Answer RightAnswer::D
Explanation [[Explanation::

Educational Objective: Multiple ring enhancing lesions in the brain of an HIV infected patient is highly concerning for cerebral Toxoplasmosis. Pyrimethamine is the preferred therapy.
References: ]]

Approved Approved::No
Keyword
Linked Question Linked::
Order in Linked Questions LinkedOrder::